
Caplin Point Laboratories Shows Trend Reversal Amid High Volatility and Sector Outperformance
2025-04-03 09:30:32Caplin Point Laboratories experienced notable activity on April 3, 2025, reversing a three-day decline with a significant intraday high. The stock demonstrated high volatility and outperformed both the pharmaceuticals sector and the broader market. Over the past month, it has shown strong gains, while its long-term growth remains impressive.
Read MoreCaplin Point Laboratories Shows Mixed Technical Trends Amid Strong Long-Term Performance
2025-04-02 08:05:52Caplin Point Laboratories, a midcap player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 1981.95, slightly down from the previous close of 1987.55. Over the past year, Caplin Point has demonstrated a notable performance, with a return of 44.37%, significantly outpacing the Sensex's 2.72% return during the same period. In terms of technical indicators, the weekly MACD and KST are showing mildly bearish trends, while the monthly indicators also reflect a similar sentiment. The Bollinger Bands present a mixed picture, indicating bearish conditions on a weekly basis but mildly bullish on a monthly scale. Moving averages suggest a mildly bullish stance on a daily basis, although the overall trend remains neutral according to Dow Theory. Caplin Point's performance over various time frames highlights i...
Read More
Caplin Point Laboratories Shows Strong Performance Amid Broader Market Trends
2025-03-06 10:20:23Caplin Point Laboratories has experienced significant activity, gaining 5.14% on March 6, 2025, and outperforming its sector. The stock has shown consecutive gains over three days, with a total return of 12.55%. In the broader market, the Sensex opened higher but remains near its 52-week low.
Read More
Caplin Point Laboratories Shows Trend Reversal Amid Broader Market Volatility
2025-03-04 14:35:21Caplin Point Laboratories has seen a significant rebound today after a six-day decline, reaching an intraday high amid notable volatility. Despite this uptick, the stock remains below key moving averages and has experienced declines over the past week and month, though it has gained over the past year. The broader market, represented by the Sensex, is also facing challenges.
Read More
Caplin Point Laboratories Faces Continued Stock Decline Amid Sector Underperformance
2025-03-03 10:15:46Caplin Point Laboratories has faced a notable decline in its stock performance, falling for six consecutive days and experiencing a significant drop over the past month. The company's shares are currently trading below key moving averages, highlighting ongoing challenges in the pharmaceuticals sector.
Read More
Caplin Point Laboratories Faces Sustained Decline Amid Broader Market Challenges
2025-02-28 12:35:20Caplin Point Laboratories has faced a significant decline in its stock price, underperforming compared to the broader Pharmaceuticals & Drugs sector. The stock has recorded losses for five consecutive days and is trading below key moving averages, reflecting ongoing challenges in the current market environment.
Read More
Caplin Point Laboratories Shows Strong Performance Amidst Market Volatility in Pharmaceuticals Sector
2025-02-19 15:05:23Caplin Point Laboratories experienced significant trading activity, outperforming its sector and the Sensex on February 19, 2025. The stock's performance showed short-term strength, although it faced challenges over the past month, reflecting the volatility inherent in the pharmaceutical industry.
Read More
Caplin Point Laboratories Faces Continued Stock Decline Amid Market Volatility in February 2025
2025-02-14 13:45:44Caplin Point Laboratories has seen a significant decline in its stock price, dropping for two consecutive days and experiencing an 18.30% decrease over the past month. The company's performance has lagged behind its sector, reflecting ongoing volatility and challenges in the current market environment.
Read More
Caplin Point Laboratories Faces Intraday Volatility Amid Broader Market Challenges
2025-02-10 12:05:18Caplin Point Laboratories has faced notable stock volatility on February 10, 2025, with significant intraday fluctuations. The stock opened positively but quickly reversed, reflecting mixed short-term performance. Over the past month, it has declined substantially, contrasting with the broader market's minor decrease, indicating ongoing challenges for the company.
Read MoreCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
03-Apr-2025 | Source : BSECompliance Certificate under regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended March 31 2025 is enclosed.
Announcement under Regulation 30 (LODR)-Acquisition
02-Apr-2025 | Source : BSECaplin Point Laboratories Limited informed that the Board of Directors of Caplin Point Far East Limited Hong Kong a material subsidiary of the Company had approved the investment in Neoethicals Chile SpA.
Cautionary Letter From NSE And BSE On March 28 2025
29-Mar-2025 | Source : BSEEnclosing a copy of cautionary e-mail received from National Stock Exchange of India Limited and BSE Limited with respect to the intimation of Schedule of Investors/ Analysts Meet/ Call on August 30 2024.
Corporate Actions
No Upcoming Board Meetings
Caplin Point Laboratories Ltd has declared 125% dividend, ex-date: 23 Sep 24
Caplin Point Laboratories Ltd has announced 2:10 stock split, ex-date: 19 Oct 16
No Bonus history available
No Rights history available